A nested case-control study was conducted in two trials of prophylaxis for Mycobacterium avium complex (MAC) infection to describe the specific signs, symptoms, and laboratory abnormalities of MAC disease in AIDS. tions of disseminated disease [9, 10], and the lack of a wellavium complex and which are related to the underlying human matched cohort of patients with similar severity of HIV disease immunodeficiency virus (HIV) infection or other concomitant but without M. avium complex infection [7, 8] . To overcome illnesses. Fever, weight loss, night sweats, fatigue, diarrhea, these limitations, we evaluated the occurrence of disseminated lymphadenopathy, organomegaly, anemia, and elevated liver M. avium complex disease in patients who were enrolled in the placebo arms of two identical studies of M. avium complex prophylaxis [11]. These patients were from many geographic sites in the United States and Canada, fulfilled standardized Received 2 August 1996; revised 31 January 1997. eligibility criteria, were followed using uniform definitions of signs and symptoms associated with M. avium complex disease
Disseminated Mycobacterium avium complex disease is now function values have all been reported as manifestations of disseminated M. avium complex infection. However, all of the most common bacterial infection among persons with advanced AIDS [1 -4] , and it has been estimated that up to onethese signs and symptoms have also been associated with advanced HIV infection itself, as well as with other opportunistic fourth of all AIDS patients will acquire this infection during their lifetimes [5] . Despite the occurrence of M. avium complex infections and malignancies. disease in large numbers of patients, its clinical manifestations Prior studies of disseminated M. avium complex infection and natural history have not been well delineated. While retrohave been limited by the analysis of data from patients in a spective and descriptive studies have reported the signs and single geographic region [6 -8] , the lack of uniform methods symptoms present in persons with M. avium complex disease for the detection of M. avium complex or standardized defini- [1, 3 -10] , it is not clear which clinical features are due to M.
tions of disseminated disease [9, 10] , and the lack of a wellavium complex and which are related to the underlying human matched cohort of patients with similar severity of HIV disease immunodeficiency virus (HIV) infection or other concomitant but without M. avium complex infection [7, 8] . To overcome illnesses. Fever, weight loss, night sweats, fatigue, diarrhea, these limitations, we evaluated the occurrence of disseminated lymphadenopathy, organomegaly, anemia, and elevated liver M. avium complex disease in patients who were enrolled in the placebo arms of two identical studies of M. avium complex prophylaxis [11] . These patients were from many geographic sites in the United States and Canada, fulfilled standardized clinical status, and had blood drawn monthly for mycobacterial bacteremia, additional comparisons were made at each of the 5 avium complex disease, as previously reported [11] . For the purmonths preceding the time of M. avium complex bacteremia (or pose of this analysis, only patients who were randomly assigned the equivalent time for the controls). Survival was assessed in to receive placebo were included. At enrollment, patients were terms of days following the date of the first blood culture positive required to be at least 18 years old, have £200/mm 3 CD4 lymphofor M. avium complex. All statistical tests were two-sided and cytes, and have a prior AIDS-defining illness [12] . All patients were conducted at a .05 level of significance. were required to be receiving antiretroviral therapy and prophylaxis against Pneumocystis carinii at study entry. Patients were excluded if either of 2 baseline blood cultures or a baseline stool
Results
culture was positive for M. avium complex. They were prohibited from taking any drugs with antimycobacterial activity during the Patients were recruited from February 1990 through January trials. Patients were evaluated every 4 weeks using standardized 1992 at 73 centers in the United States and Canada; 580 were forms for recording changes in symptoms or physical findings. At randomized to receive placebo within the 2 studies. These paeach visit, patients had complete blood cell counts and selected tients were predominantly male (97%) and white (88%), and chemistry tests performed. Lymphocyte subset evaluations were they had a mean age of 37.7 years ({8.1). The average patient done every 3 months.
had been diagnosed with AIDS for slightly over 1 year, and
Patients had a single blood culture for mycobacteria done at the mean and median CD4 cell counts of the population were each monthly visit. All cultures were processed at one of two 56 and 36/mm 3 , respectively.
central laboratories using broth radiometric techniques [13] . Patients who were found to have M. avium complex bacteremia
Of the 580 patients, 9 had M. avium complex bacteremia at were classified as having disseminated disease. These patients were enrollment and were removed from further analysis, leaving phatase at baseline. There were no differences between persons was evaluated using individuals in the disseminated M. avium States and Canada. Even more important, the presence of a patients with M. avium complex disease had significantly lower weights and Karnofsky scores, and a higher proportion had fever, night sweats, and abdominal pain than patients in the matched cohort of patients with equally severe immunosupwere diagnosed early in their disease because of the monthly culture of blood for mycobacteria. This is supported by the pression allowed the impact of disseminated M. avium complex disease to be distinguished from other changes related to adhigh frequency of asymptomatic patients. The abnormalities in signs and symptoms shown in table 2 may more accurately vanced HIV infection. Overall, the 1-year incidence of M. avium complex bacteremia was 24.6%, with the highest 1-year reflect the abnormalities that present at the onset of disseminated M. avium complex disease than in series reporting abnorrates for individuals with õ75 CD4 cells/mm 3 . This incidence is similar to that reported by others [7, 9, 14] . malities in persons who may have had M. avium complex infection for some time prior to diagnosis. Another indication The only clinically important predictor of the development of M. avium complex bacteria was the CD4 lymphocyte count that our patients may have been diagnosed earlier in their disease is that we found the hemoglobin levels to be substantially at baseline. Patients who developed disseminated M. avium complex disease had significantly lower mean CD4 cell counts higher in our patients than in patients in other studies. Our patients had a mean hemoglobin concentration of 10.9 g/dL at (35 vs. 61/mm 3 ) than persons who did not (table 1) . Several other characteristics were also correlated with the development the time of initial diagnosis of M. avium complex bacteremia, while others have reported that 85% of patients have a hemoof M. avium complex disease; however, the small differences in values are not likely to be clinically useful. As a group, globin concentration of õ8.5 g/dL [4] . Other abnormalities reported as being associated with M. avium complex disease persons who became infected with M. avium complex weighed less at baseline (68.8 vs. 72.1 kg). In addition, there were include weight loss and fatigue, reported for ú60% of our patients, and abdominal abnormalities (including pain and diarstatistically significant elevations in liver function values in persons who developed M. avium complex disease, although rhea), found in about one-fourth to one-third of our patients. To differentiate the symptoms associated with M. avium the absolute differences in levels of SGOT, bilirubin, and alkaline phosphatase were small. In other series, anemia has been complex disease from symptoms due to other HIV-related abnormalities in patients with equally advanced HIV disease, we associated with an increased risk of developing M. avium complex bacteremia; however, in our study, the baseline hemoglomatched cases of M. avium complex disease with controls by CD4 cell count. CD4 cell counts were used as the most powerbin level was only marginally lower in patients who developed M. avium complex bacteremia (12.2 vs. 12.5 g/dL, P Å .06).
ful single predictor of HIV disease progression, as virus load measurements were not available for this cohort. The data in At the onset of M. avium complex bacteremia, there were fewer signs and symptoms than have been reported by others table 2 demonstrate that many of the signs and symptoms associated with M. avium complex disease occur in individuals (table 2) . For example, in our group, only 48% of patients had fever, and 24% had night sweats. In a study of 114 patients at the same stage of HIV disease but without M. avium complex infection. Despite the overlap of abnormalities between the with disseminated M. avium complex disease reported from Atlanta, 84% had fever and 44% had night sweats at diagnosis 2 groups, this study prospectively confirmed the association between disseminated M. avium complex disease and weight [15] . In a compilation of symptoms reported from 10 reported studies, Benson and Ellner [4] found that 87% of persons with loss, abdominal pain, fever, night sweats, anemia, a low Karnofsky score, and an increase in level of serum alkaline phosdisseminated M. avium complex disease had fever and 78% had night sweats [4] . The fact that fewer patients in our cohort phatase. Such associations have previously been reported only from cross-sectional and cohort studies and are assumed to had fever and night sweats suggests that patients in our study / 9d2b$$jy01 05-30-97 17:24:37 jinfa UC: J Infect represent manifestations of disseminated M. avium complex soon becomes persistent, and the number of mycobacteria in the blood increases over time [17 -19] . Thus, M. avium comdisease because they have not been reported to be predictors of disease. Moreover, those studies did not differentiate the plex disease in the absence of bacteremia or associated with bacteremia of low titer is associated with early disease, while symptoms of M. avium complex infection from those of other HIV-associated illnesses and may have combined persons with multiorgan system involvement and high-titer bacteremia are associated with long-standing disease. Such long-standing disearly-and late-stage M. avium complex disease. The present study, where patient blood was cultured monthly, identified ease is associated with greater morbidity, poorer response to antimycobacterial agents, and shorter survival [15] . disseminated M. avium complex disease and its associated abnormalities at the onset of dissemination. An elevated serum
To examine these time-dependent changes, we compared the clinical and laboratory characteristics of the patients with LDH level was also associated with disseminated M. avium complex disease. Although not previously reported in associadisseminated M. avium complex disease with those of the control cohort at each month, from 5 months before to the initial tion with M. avium complex disease, LDH level has been noted to be a harbinger of P. carinii pneumonia in patients with AIDS diagnosis of M. avium complex bacteremia (table 3) . Using this technique, we were able to define the time at which significant [16] . The clinical relevance of LDH as a marker for M. avium complex disease remains to be elucidated.
differences occurred between the cases and controls for each individual characteristic. The pathophysiology of M. avium complex disease has not been well studied. It appears that this disease is acquired from Patients with disseminated M. avium complex disease had a clinical prodrome that was identifiable 3 months before the the environment through the gastrointestinal tract or, less commonly, the lung [4, 5] . Foci of localized infection in the gastrofirst positive blood culture. Such patients had a significant loss of weight compared with the controls at this point, which conintestinal or respiratory tract eventually produce bacteremia, which then spreads disease to internal organs, such as the spleen tinued to the time of dissemination. One to 2 months prior to the first detection of M. avium complex in the blood, patients and bone marrow. Bacteremia may be transient at first, but / 9d2b$$jy01 05-30-97 17:24:37 jinfa UC: J Infect reported more fever, and lower hemoglobin and higher LDH M. avium complex disease and should receive prophylactic antibiotics. Second, because such patients have fever and levels could be detected. Many of the other abnormalities associated with disseminated M. avium complex disease, including weight loss from M. avium complex infection prior to the occurrence of bacteremia, examination of tissues for evidence of M. a lower Karnofsky score, abdominal pain, night sweats, diarrhea, and an elevated level of alkaline phosphatase could be avium complex may be warranted when blood cultures are negative; biopsy of the gut or liver may be useful, but stool detected only at the time of dissemination. Thus, it appears that most of the manifestations of disseminated M. avium complex culture is not [25] . Third, when M. avium complex infection is suspected, blood should be cultured monthly to detect mycodisease appear closely before or at the time of initial M. avium complex bacteremia. However, the occurrence of fevers and bacteremia at the earliest possible time because early detection of M. avium complex disease is associated with fewer sympweight loss 2 -3 months before the first positive blood culture suggests that localized disease is present well before bactertoms and longer survival. Fourth, because fever and weight loss from other causes are common in persons with advanced emia. This is consistent with animal models of disseminated M. avium complex disease [20, 21] and observations at autopsy AIDS, we do not recommend presumptive treatment for M. avium complex disease. Improved methods for early diagnosis that M. avium complex is found in intestines, liver, and spleen in most patients who die of disseminated M. avium complex of M. avium complex disease are needed. disease. An autopsy study failed to identify sites of localized disease in some patients, but this failure may have been due
